GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (WBO:ABT) » Definitions » EPS without NRI

Abbott Laboratories (WBO:ABT) EPS without NRI

: €3.86 (TTM As of Dec. 2023)
View and export this data going back to 2018. Start your Free Trial

Abbott Laboratories's earnings per share without non-recurring items for the three months ended in Dec. 2023 was €1.09. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Dec. 2023 was €3.86.

During the past 12 months, Abbott Laboratories's average earnings per share (NRI) Growth Rate was 13.50% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 21.30% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 26.10% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 17.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Abbott Laboratories's EPS without NRI or its related term are showing as below:

WBO:ABT' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -46.2   Med: 13.6   Max: 136.5
Current: 21.3

During the past 13 years, Abbott Laboratories's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 136.50% per year. The lowest was -46.20% per year. And the median was 13.60% per year.

WBO:ABT's 3-Year EPS without NRI Growth Rate is ranked better than
64.96% of 702 companies
in the Medical Devices & Instruments industry
Industry Median: 9.95 vs WBO:ABT: 21.30

Abbott Laboratories's EPS (Diluted) for the three months ended in Dec. 2023 was €0.83. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €3.02.

Abbott Laboratories's EPS (Basic) for the three months ended in Dec. 2023 was €0.84. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €3.04.


Abbott Laboratories EPS without NRI Historical Data

The historical data trend for Abbott Laboratories's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.89 2.04 3.49 3.69 4.07

Abbott Laboratories Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS without NRI Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.97 0.70 1.00 1.07 1.09

Competitive Comparison

For the Medical Devices subindustry, Abbott Laboratories's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abbott Laboratories PE Ratio without NRI Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Abbott Laboratories's PE Ratio without NRI falls into.



Abbott Laboratories EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €3.86

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Abbott Laboratories  (WBO:ABT) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Abbott Laboratories EPS without NRI Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Abbott Laboratories (WBO:ABT) Business Description

Address
100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.

Abbott Laboratories (WBO:ABT) Headlines

From GuruFocus

Q2 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2022 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q3 2021 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2020 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q2 2023 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024

Q4 2019 Abbott Laboratories Earnings Call Transcript

By GuruFocus Research 01-22-2024